Skip to main content

Table 2 Reasons for which aortic valve replacement was excluded as therapeutic option in patients without high Euroscope who underwent treatment allocation to transcatheter valve implantations (TAVI = 55 patients), baloon aortic valvuloplasty (BAV = 13 patients), medicaltherapy (MT = 20 patients)

From: Does treatment assignment influence the prognosis of patients with symptomatic severe aortic stenosis?

Reasons Number of patients (88) TAVI (55 patients) BAV (13 patients) MT (20 patients)
Advance age (<75 years) 30 16 4 10
Severe chronic obstructive pulmonary disease 14 10 2 2
Porcelain ascending aorta 11 10 0 1
Severe chronic kidney disease 12 8 1 3
Sclerodermia and/or severe arterial pulmonary hypertension 5 3 2 0
Previous coronary-aortic by-pass graft 3 2 0 1
Refuse to undergo surgery 4 1 2 1
Hepatic cirrhosis 3 3 0 0
Thoracic deformation 2 1 1 0
Sever ascending aorta dilatation 1 1 0 0
Cancer 2 0 1 1
Previous stroke 1 0 0 1